The conversation around GLP-1 drugs is evolving, and with ongoing developments, they may soon become a staple in weight management and health improvement strategies.
Coverage availability for Zepbound may also expand for some commercially insured patients later in 2026, as CVS Caremark has announced plans to restore Zepbound to its standard commercial formularies beginning in October
How It Works We make the entire process effortless: Schedule your EKG with our concierge team Receive your test at home or in-officewhichever is more convenient Have your results interpreted by a Desert Mobile Medical physician Discuss findings during a $99 telemedicine visit Follow your personalized plan with confidence As a result, you enjoy a seamless, guided, and reassuring experience from beginning to end
PMID: 24818783 9
Factors Indicating Need for Dose Escalation Increase doses when minimal subjective improvements after 3-4 weeks at current dose, IGF-1 levels show minimal or no meaningful increase from baseline after an adequate trial period (e.g., 812 weeks), good tolerance without significant side effects suggesting room for higher dosing, and treatment goals require more aggressive approach than current dose provides